Welcome to our dedicated page for Quantum SEC filings (Ticker: QMCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Quantum Corporation filings document the regulatory record for a Delaware technology company that provides data management solutions for unstructured data. Its Form 8-K reports cover quarterly and preliminary financial results, executive appointments, and material definitive agreements affecting the company’s capital structure.
The company’s registration statements disclose securities offering matters, while proxy materials cover annual meeting governance and shareholder voting matters. Recent capital-structure disclosures include a completed debt exchange involving senior secured convertible notes, alongside related agreement and shareholder-approval documentation.
Quantum Corporation is registering 2,653,308 shares of common stock for resale by Dialectic Technology SPV LLC, issuable upon exercise of a Forbearance Warrant. The warrant covers shares equal to 19.9% of the outstanding common stock as of the Transaction Agreement date, has a cash or net-share exercise feature at an exercise price of $8.81 per share, and is exercisable for seven years. Shares outstanding were 13,333,208 as of September 30, 2025.
The warrant was issued as consideration under a Fifteenth Amendment to a term loan, which defers cash interest for the quarters ending September 30 and December 31, 2025 while increasing the interest rate on the affected loans by 2.00%. Quantum will not receive proceeds from any resale of shares by the selling stockholder, but will receive cash if the warrant is exercised, which it plans to use for working capital, general corporate purposes and debt repayment. The selling stockholder also holds a right to require Quantum to repurchase the warrant for $20.0 million in specified events.
Quantum Corporation filed a resale registration statement covering up to 2,653,308 shares of common stock issuable upon exercise of a warrant held by Dialectic Technology SPV LLC. The warrant, issued as consideration for amendments and forbearance under Quantum’s term loan agreement, has a cash or net-share exercise feature, a $8.81 exercise price and a seven-year term, and represents 19.9% of shares outstanding on the transaction date. Quantum will not receive proceeds from any resale of shares by the selling stockholder, but will receive cash if the warrant is exercised for cash, which it may use for working capital, general corporate purposes and debt repayment. Quantum had 13,333,208 shares of common stock outstanding as of September 30, 2025.
Quantum Corporation (QMCO) filed its 10-Q reporting a weaker quarter. Revenue was $62.7 million, down from $71.8 million a year ago, as product and service lines both declined. Gross margin fell to 37.6% from 42.7%.
The company posted a net loss of $46.5 million versus $12.2 million last year, driven by a $33.3 million loss on debt extinguishment and $3.2 million in restructuring charges. Cash and cash equivalents were $14.7 million, with total current liabilities of $241.7 million and a stockholders’ deficit of $160.5 million. Remaining performance obligations totaled $130.3 million, providing contracted revenue visibility.
Liquidity and capital structure updates: management disclosed substantial doubt about the ability to continue as a going concern. On September 23, 2025, Quantum agreed to exchange Dialectic’s term loans for senior secured convertible notes, subject to stockholder approval, and issued a forbearance warrant covering up to 2,653,308 shares at an $8.81 exercise price. The PNC credit facility was terminated on August 13, 2025. Under its $200 million SEPA, Quantum issued about 7.5 million shares for $82.8 million in net proceeds as of September 30, 2025.
Quantum Corporation reported financial results for the fiscal quarter ended September 30, 2025 and furnished the accompanying earnings press release as Exhibit 99.1 in a Form 8-K.
The information was provided under Item 2.02 and is expressly furnished, not filed under the Exchange Act, and will not be incorporated by reference into Securities Act filings. The company also listed Exhibit 104 for the cover page interactive data file.
Quantum Corporation (QMCO) reported an insider transaction on Form 4: a director received a grant of 1,000 restricted stock units (RSUs) on 11/01/2025 at a stated price of $0 per unit.
The RSUs vest in full on the earlier of November 1, 2026 or the date of the company’s next annual stockholder meeting, subject to continued board service. Following the grant, beneficial ownership stands at 1,000 common shares, held directly.
Quantum Corporation (QMCO) reported a Form 4 showing a director received 1,000 shares of common stock via a restricted stock unit (RSU) grant on November 1, 2025 at a stated price of $0.
The RSUs vest in full on the earlier of November 1, 2026 or the date of the company’s next annual stockholder meeting, contingent on continued service on the Board. Following the transaction, the reporting person beneficially owned 1,000 shares, held directly.
Quantum Corporation (QMCO) reported an insider equity grant. President & CEO and Director Hugues Meyrath acquired 37,500 shares of common stock via RSUs at $0 on 11/01/2025. He was also granted an employee stock option for 50,000 shares at an exercise price of $9.44.
The RSUs vest in four equal annual installments beginning July 1, 2026 (vesting commencement date July 1, 2025). The stock option vests on the same four-annual-installment schedule starting July 1, 2026. After these transactions, 62,200 common shares were beneficially owned directly, and 50,000 options were held.
Quantum Corporation (QMCO) filed its 2025 proxy for a virtual annual meeting on December 16, 2025 (record date October 20, 2025). The Board seeks approval to elect seven directors and to authorize key financing actions tied to its balance‑sheet restructuring.
Proposals 2 and 3 request approval to issue senior secured convertible notes in a debt exchange with Dialectic, converting approximately $52 million of term loans into notes maturing three years after closing at 10% PIK interest and an initial $10.00 conversion price, subject to quarterly resets not below $4.00. At that price, full conversion would equal about 29.4% of shares post‑conversion. Proposal 4 covers potential issuances above Nasdaq’s 20% cap under anti‑dilution provisions of a Forbearance Warrant for 2,653,308 shares at $8.81. Combined conversion and warrant exercise could reach about 38.1%, and could exceed 50% with adjustments or additional notes. The notes include quarterly minimum liquidity covenants rising from $3.75M to $7.5M in 2026.
Proposal 5 amends the 2023 Long‑Term Incentive Plan, adding 1,400,000 shares and removing individual award limits; roughly 425,000 promised grants depend on share availability. Proposals 6–8 cover say‑on‑pay, auditor ratification, and potential adjournment. The Board recommends voting “FOR” all proposals.